Wed, 26 Aug 2026

short seller

fraud

Blue Orca: HK-listed China Medical System exaggerates financial performance

FutureCFO Editors February 6, 2020

Blue Orca said today that aggregate net profits at China Medical System’s subsidiaries in China were 49% less than reported

fraud

HK-listed firm accused of fraud: Shares fell 24.8% before trading halt

FutureCFO Editors June 24, 2019

Short seller Bonitas Research accused Hong Kong-listed Bosideng (HKEx: 3998) of public market fraud, which resulted in the firm’s shares

Recent posts

ACCA pitches recommendations to support Hong Kong’s economic development plan

Where the office of the CFO is headed

MAS unveils measures for Singapore’s asset management industry

Philippine central bank calls for Southeast Asian regulators to ‘step up’ vs financial, cybersecurity risks

Reshaping expectations in the Finance function

Singapore remains as centre hub for Southeast Asia M&A activities

Subscribe